After reviewing Pfizer’s data, the advisory panel voted to support administering the vaccines in children 5 to 11.
After reviewing Pfizer’s data, the advisory panel voted to support administering the vaccines in children 5 to 11.
+6012 275 0035
Daily top news delivered to your inbox FREE. Subscribe to enjoy privilege.